Tricyclic heteroaryl compounds as inhibitors of TYK2 and / or JAK1
TW202631631APending Publication Date: 2026-08-01INCYTE CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114138418
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-04
- Filing Date
- 2025-10-03
- Publication Date
- 2026-08-01
Abstract
The present application provides tricyclic heteroaryl compounds that modulate the activity of the JAK1 and / or TYK2, which are useful in the treatment of various disorders and diseases, including skin, respiratory, ophthalmic, and rectal diseases and disorders, cancer, and neuroinflammation.
Need to check novelty before this filing date? Find Prior Art